From: Renal cell carcinoma metastasis to thyroid tumor: a case report and review of the literature
Case number | Authors | Receiving thyroid neoplasm | Interval | Immunohistochemistry |
---|---|---|---|---|
1 | Bohn et al.[3] | Papillary carcinoma | 2 Y | THY (−) RCC marker + |
2 | Follicular adenoma | NA | THY (−) | |
3 | Chacho et al. cited by Ryska[4] | Follicular adenoma | Synchronous | Not done |
4 | Papillary carcinoma, follicular variant | 2 Y | THY (−) CK19 (−) | |
5 | Wolf et al.[5] | Microfollicular adenoma | NA | Not done |
6 | Ryska and Cap[4] | Oncocytic carcinoma | 13 M | THY (−), vimentin (+), calcitonin (−), EMA (+), CK AE1-AE3 (+) |
7 | Qian et al.[6] | Hürthle adenoma | Synchronous | TTF-1 (−), THY (−), CD10 (+), vimentin (+) |
8 | Koo et al. cited by Bohn[3] | Follicular adenoma | 5 Y | TTF-1 (−), THY (−), calcitonin (−). Equivocal CK and CD10 |
9 | Yu et al.[7] | Papillary carcinoma | 3 Y | THY (−), TTF-1 (−), CD10 (+), vimentin (+), RCC antigen (−) |
10 | Medas et al. (present case) | Microfollicular adenoma | 6 Y | TTF-1 (−), THY (−), CD10 (+) |